Purchase of Proleukin

{
  "awards": [
    {
      "aboveThreshold": true,
      "contractPeriod": {
        "endDate": "2025-05-30T23:59:59+01:00",
        "startDate": "2025-05-09T00:00:00+01:00"
      },
      "documents": [
        {
          "datePublished": "2025-04-17T08:47:11+01:00",
          "description": "Transparency notice on Find a Tender",
          "documentType": "awardNotice",
          "format": "text/html",
          "id": "015729-2025",
          "noticeType": "UK5",
          "url": "https://www.find-tender.service.gov.uk/Notice/015729-2025"
        }
      ],
      "id": "1",
      "items": [
        {
          "additionalClassifications": [
            {
              "description": "Pharmaceutical products",
              "id": "33600000",
              "scheme": "CPV"
            }
          ],
          "deliveryAddresses": [
            {
              "country": "GB",
              "countryName": "United Kingdom",
              "region": "UKL22"
            }
          ],
          "id": "1",
          "relatedLot": "1"
        }
      ],
      "mainProcurementCategory": "goods",
      "milestones": [
        {
          "dueDate": "2025-04-30T23:59:59+01:00",
          "id": "1",
          "status": "scheduled",
          "type": "futureSignatureDate"
        }
      ],
      "relatedLots": [
        "1"
      ],
      "status": "pending",
      "title": "Purchase of Proleukin for Medical Trial",
      "value": {
        "amount": 220000.0,
        "amountGross": 220000.0,
        "currency": "EUR"
      }
    }
  ],
  "buyer": {
    "id": "GB-PPON-PHVT-4343-HWYR",
    "name": "Cardiff University"
  },
  "date": "2025-04-17T08:47:11+01:00",
  "id": "015729-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-050471",
  "parties": [
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "Cardiff",
        "postalCode": "CF24 4HQ",
        "region": "UKL22",
        "streetAddress": "Procurement Services"
      },
      "contactPoint": {
        "email": "procurement@cardiff.ac.uk"
      },
      "details": {
        "classifications": [
          {
            "description": "Public authority - sub-central government",
            "id": "publicAuthoritySubCentralGovernment",
            "scheme": "UK_CA_TYPE"
          },
          {
            "description": "Welsh devolved regulations apply",
            "id": "GB-WLS",
            "scheme": "UK_CA_DEVOLVED_REGULATIONS"
          }
        ],
        "url": "http://www.cardiff.ac.uk/business/why-work-with-us/for-suppliers"
      },
      "id": "GB-PPON-PHVT-4343-HWYR",
      "identifier": {
        "id": "PHVT-4343-HWYR",
        "scheme": "GB-PPON"
      },
      "name": "Cardiff University",
      "roles": [
        "buyer"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "description": "Cardiff University\u0027s School of Medicine are conducting research which requires trial patients to be issued with doses of Proleukin. This is an essential element of the research and cannot be changed. Cardiff University intends to purchase a number of these Proluekin doses in order for the research to be conducted.",
    "documents": [
      {
        "description": "Not published",
        "documentType": "conflictOfInterest",
        "id": "conflictOfInterest"
      }
    ],
    "id": "ocds-h6vhtk-050471",
    "legalBasis": {
      "id": "2023/54",
      "scheme": "UKPGA",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
    },
    "lots": [
      {
        "id": "1",
        "status": "complete"
      }
    ],
    "procurementMethod": "direct",
    "procurementMethodDetails": "Direct award",
    "procurementMethodRationale": "As far as we are currently aware, the only source available to the University to source Proleukin from is a pharmaceutical company in Ireland, who have exclusive distribution rights from the US manufacturer. We are currently chasing a formal confirmation of this, following an informal confirmation being received previously. Once this confirmation is received, we intend on directly awarding to the Irish distributor. ",
    "procurementMethodRationaleClassifications": [
      {
        "id": "singleSuppliersIntellectualPropertyExclusiveRights"
      }
    ],
    "riskDetails": "There are limited ways the performance of this one-off, supply contract could be hindered. However, some potential risks include issues with delivery, inconsistent quality of the sourced Proleukin etc. ",
    "status": "complete",
    "title": "Purchase of Proleukin"
  }
}